301 related articles for article (PubMed ID: 16557208)
21. 99mTc-sestamibi brain SPECT after chemoradiotherapy is prognostic of survival in patients with high-grade glioma.
Beauchesne P; Pedeux R; Boniol M; Soler C
J Nucl Med; 2004 Mar; 45(3):409-13. PubMed ID: 15001680
[TBL] [Abstract][Full Text] [Related]
22. [Monitoring of irradiated brain metastases using MR perfusion imaging and 1H MR spectroscopy].
Weber MA; Lichy MP; Thilmann C; Günther M; Bachert P; Maudsley AA; Delorme S; Schad LR; Debus J; Schlemmer HP
Radiologe; 2003 May; 43(5):388-95. PubMed ID: 12764588
[TBL] [Abstract][Full Text] [Related]
23. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
[TBL] [Abstract][Full Text] [Related]
24. Technetium-99m sestamibi brain SPECT in the follow-up of glioma for evaluation of response to chemotherapy: first results.
Prigent-Le Jeune F; Dubois F; Perez S; Blond S; Steinling M
Eur J Nucl Med Mol Imaging; 2004 May; 31(5):714-9. PubMed ID: 14985865
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation for degree of malignancy and prognosis of patients with brain glioma using 99Tcm-MIBI brain SPECT].
Fan YX; Luo RC; Li GP; Zheng H; Huang K
Ai Zheng; 2004 Jun; 23(6):689-92. PubMed ID: 15191672
[TBL] [Abstract][Full Text] [Related]
26. Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study.
Laprie A; Catalaa I; Cassol E; McKnight TR; Berchery D; Marre D; Bachaud JM; Berry I; Moyal EC
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):773-81. PubMed ID: 18262090
[TBL] [Abstract][Full Text] [Related]
27. The use of proton MRS in the differential diagnosis of brain tumors and tumor-like processes.
Gajewicz W; Papierz W; Szymczak W; Goraj B
Med Sci Monit; 2003 Sep; 9(9):MT97-105. PubMed ID: 12960934
[TBL] [Abstract][Full Text] [Related]
28. 99mTc-MIBI brain SPECT as an indicator of the chemotherapy response of recurrent, primary brain tumors.
Bleichner-Perez S; Le Jeune F; Dubois F; Steinling M
Nucl Med Commun; 2007 Dec; 28(12):888-94. PubMed ID: 18090213
[TBL] [Abstract][Full Text] [Related]
29. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis and treatment of progressive space-occupying radiation necrosis following stereotactic radiosurgery for brain metastasis: value of proton magnetic resonance spectroscopy.
Kimura T; Sako K; Tohyama Y; Aizawa S; Yoshida H; Aburano T; Tanaka K; Tanaka T
Acta Neurochir (Wien); 2003 Jul; 145(7):557-64; discussion 564. PubMed ID: 12910398
[TBL] [Abstract][Full Text] [Related]
31. Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study.
Matsumura A; Isobe T; Anno I; Takano S; Kawamura H
J Clin Neurosci; 2005 May; 12(4):416-20. PubMed ID: 15925772
[TBL] [Abstract][Full Text] [Related]
32. Neuroradiological findings (MRS, MRI, SPECT) in infantile neuronal ceroid-lipofuscinosis (infantile CLN1) at different stages of the disease.
Vanhanen SL; Puranen J; Autti T; Raininko R; Liewendahl K; Nikkinen P; Santavuori P; Suominen P; Vuori K; Häkkinen AM
Neuropediatrics; 2004 Feb; 35(1):27-35. PubMed ID: 15002049
[TBL] [Abstract][Full Text] [Related]
33. Comparison of diffusion tensor, dynamic susceptibility contrast MRI and (99m)Tc-Tetrofosmin brain SPECT for the detection of recurrent high-grade glioma.
Alexiou GA; Zikou A; Tsiouris S; Goussia A; Kosta P; Papadopoulos A; Voulgaris S; Tsekeris P; Kyritsis AP; Fotopoulos AD; Argyropoulou MI
Magn Reson Imaging; 2014 Sep; 32(7):854-9. PubMed ID: 24848292
[TBL] [Abstract][Full Text] [Related]
34. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
[TBL] [Abstract][Full Text] [Related]
35. Comparison of 1H-MRS-detected metabolic characteristics in single metastatic brain tumors of different origin.
Chernov MF; Ono Y; Kubo O; Hori T
Brain Tumor Pathol; 2006 Apr; 23(1):35-40. PubMed ID: 18095117
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors.
Weber MA; Zoubaa S; Schlieter M; Jüttler E; Huttner HB; Geletneky K; Ittrich C; Lichy MP; Kroll A; Debus J; Giesel FL; Hartmann M; Essig M
Neurology; 2006 Jun; 66(12):1899-906. PubMed ID: 16801657
[TBL] [Abstract][Full Text] [Related]
37. Attenuation-corrected 99mTc-MIBI SPECT in overweight patients with chronic ischaemic dysfunction: a comparison to NH3 PET and implications for the diagnosis of myocardial viability.
Roelants V; Bernard X; Walrand S; Bol A; Coppens A; Jamart J; Melin J; Vanoverschelde JL
Nucl Med Commun; 2006 Oct; 27(10):815-21. PubMed ID: 16969265
[TBL] [Abstract][Full Text] [Related]
38. Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas.
Prat R; Galeano I; Lucas A; Martínez JC; Martín M; Amador R; Reynés G
J Clin Neurosci; 2010 Jan; 17(1):50-3. PubMed ID: 19959364
[TBL] [Abstract][Full Text] [Related]
39. [Serial MRI, SPECT and 1H-MRS findings in a case of herpes simplex encephalitis].
Tajima Y; Isonishi K; Kashiwaba T; Tashiro K
No To Shinkei; 1998 Nov; 50(11):1023-7. PubMed ID: 9866129
[TBL] [Abstract][Full Text] [Related]
40. Sestamibi technetium-99m brain single-photon emission computed tomography to identify recurrent glioma in adults: 201 studies.
Le Jeune FP; Dubois F; Blond S; Steinling M
J Neurooncol; 2006 Apr; 77(2):177-83. PubMed ID: 16314957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
